GLP2-T is a research-designated synthetic 39-amino acid peptide classified as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its structure was first described in patent filings around 2016. The molecule is built on a GIP peptide backbone and incorporates a C₂₀ fatty diacid moiety — a long-chain lipid attached via a linker — a lipidation strategy also seen in other long-acting peptide analogs.

GLP2-T has the molecular formula C₂₂₅H₃₄₈N₄₈O₆₈, a molecular weight of approximately 4,810.52 g/mol, and a CAS number of 2023788-19-2. It is supplied as a white to off-white lyophilized powder that dissolves readily in water. The lipid modification is the key structural feature that is a common modification in modern peptide analog design, distinguishing it from earlier single-target incretin peptides.

This product is strictly for research purposes only. Not approved for human or animal use.

PubChem Reference: View compound profile on NIH PubChem